In contrast to the hypothesis of a pro-fibrogenic role of PGD2 in schistosomiasis derived from in vitro studies, in our experiments, both PGD2-targeting treatments aggravated, rather than attenuated, the S. mansoni-induced fibrotic reaction in the granulomatous liver. This evidence concerns the gene HPGDS and schistosomiasis.